Table 2 |
|||||
|
Significant multivariate associations between semen outcomes and endocrine measures |
|||||
| Semen Parameter |
Endocrine Measure |
Beta (SE) |
P |
Odds Ratio (CI) |
R2 |
|
|
|||||
| Abnormal semen count (< 20 × 106) |
Baseline inhibin |
0.048 |
0.98 (0.96–0.99) |
0.14 |
|
| Baseline FSH |
0.021 |
1.69 (1.05–2.8) |
0.22 |
||
| Post Peak GnRH LH |
0.015 |
1.15 (1.03–1.3) |
0.24 |
||
| Post Peak GnRH FSH |
0.033 |
1.4 (1.0–1.9) |
0.18 |
||
| Abnormally low baseline Inhibin (< 100 pg/ml) |
0.032 |
8.2 (1.4–49.2) |
0.18 |
||
|
|
|||||
| Density |
Abnormally low baseline inhibin |
-69.5 (32.2) |
0.039 |
0.05 |
|
| Baseline testosterone |
-3.8 (1.83) |
0.046 |
0.04 |
||
| Baseline inhibin |
0.8 (0.3) |
0.01 |
0.25 |
||
|
|
|||||
| Abnormal Density (< 40 × 106/ml) |
Baseline FSH |
0.028 |
1.85 (1.1–3.2) |
0.14 |
|
|
|
|||||
| Abnormal morphology (< 2%) |
Abnormally high baseline E2 (> 50 pg/ml) |
0.013 |
37.2 (2.1–655.2) |
0.18 |
|
|
|
|||||
| Abnormal motility (< 50%) |
Abnormally high baseline E2 |
0.046 |
39.5 (1.1–1450) |
0.34 |
|
|
|
|||||
| Morphology |
Abnormally high baseline E2 |
-1.27 (0.58) |
0.036 |
0.21 |
|
|
|
|||||
|
* CI: 95% confidence interval Covariates included in models: age, abstinence, presence of physical abnormality and fever in the last two months |
|||||
|
Dalvie and Myers Journal of Occupational Medicine and Toxicology 2006 1:21 doi:10.1186/1745-6673-1-21 |
|||||
